BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27798901)

  • 21. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?
    Mizuno M; Kajiyama H; Shibata K; Mizuno K; Yamamuro O; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
    Int J Gynecol Cancer; 2012 Sep; 22(7):1143-9. PubMed ID: 22801028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture.
    Shimizu D; Sato N; Sato T; Makino K; Kito M; Shirasawa H; Kumagai J; Terada Y
    J Obstet Gynaecol Res; 2015 Mar; 41(3):432-9. PubMed ID: 25330897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.
    Bamias A; Karadimou A; Soupos N; Sotiropoulou M; Zagouri F; Haidopoulos D; Thomakos N; Rodolakis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2011 Oct; 123(1):37-42. PubMed ID: 21764430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
    Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
    Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphadenectomy in surgical stage I epithelial ovarian cancer.
    Svolgaard O; Lidegaard O; Nielsen ML; Nedergaard L; Mosgaard BJ; Lidang M; Mogensen O; Kock K; Blaakaer J; Staehr E; Andersen ES; Grove A; Høgdall C
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):256-60. PubMed ID: 24447203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer.
    Hirose S; Tanabe H; Nagayoshi Y; Hirata Y; Narui C; Ochiai K; Isonishi S; Takano H; Okamoto A
    J Gynecol Oncol; 2018 May; 29(3):e37. PubMed ID: 29533021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.
    Gouy S; Goetgheluck J; Uzan C; Duclos J; Duvillard P; Morice P
    Eur J Surg Oncol; 2012 Feb; 38(2):170-5. PubMed ID: 22104389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A non-randomized confirmatory study regarding selection of fertility-sparing surgery for patients with epithelial ovarian cancer: Japan Clinical Oncology Group Study (JCOG1203).
    Satoh T; Tsuda H; Kanato K; Nakamura K; Shibata T; Takano M; Baba T; Ishikawa M; Ushijima K; Yaegashi N; Yoshikawa H;
    Jpn J Clin Oncol; 2015 Jun; 45(6):595-9. PubMed ID: 26059697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical and survival outcomes of laparoscopic staging surgery for patients with stage I ovarian cancer.
    Lee CL; Kusunoki S; Huang CY; Wu KY; Lee PS; Huang KG
    Taiwan J Obstet Gynecol; 2018 Feb; 57(1):7-12. PubMed ID: 29458907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy equalizes the optimal cytoreduction rate to primary surgery without improving survival in advanced ovarian cancer.
    Taşkın S; Güngör M; Ortaç F; Öztuna D
    Arch Gynecol Obstet; 2013 Dec; 288(6):1399-403. PubMed ID: 23775264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.
    Matsuo K; Yoshino K; Hasegawa K; Murakami R; Ikeda Y; Adachi S; Hiramatsu K; Yokoyama T; Nishimura M; Sheridan TB; Enomoto T; Fujiwara K; Matsumura N; Konishi I; Fotopoulou C; Roman LD; Sood AK
    Gynecol Oncol; 2015 Feb; 136(2):198-204. PubMed ID: 25497604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of CA(125) in the prediction of optimal interval debulking surgery and its prognosis in patients with epithelial ovarian cancer].
    Mu T; Li XP; Wang JL; Wang SJ; Wang Y; Sun XL; Cui H; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):566-70. PubMed ID: 23141174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State of the art of surgery in advanced epithelial ovarian cancer.
    Hacker NF
    Ann Oncol; 2013 Dec; 24 Suppl 10():x27-32. PubMed ID: 24265399
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
    Ulker V; Kuru O; Numanoglu C; Akbayır O; Polat I; Uhri M
    Arch Gynecol Obstet; 2014 May; 289(5):1087-92. PubMed ID: 24213097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer.
    Wright JD; Herzog TJ; Neugut AI; Burke WM; Lu YS; Lewin SN; Hershman DL
    Obstet Gynecol; 2012 Oct; 120(4):871-81. PubMed ID: 22996105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.
    Jordan S; Steer C; DeFazio A; Quinn M; Obermair A; Friedlander M; Francis J; O'Brien S; Goss G; Wyld D; Australian Ovarian Cancer Study Group ; Webb P;
    Gynecol Oncol; 2013 May; 129(2):310-7. PubMed ID: 23403164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in treatment of epithelial ovarian cancer.
    Kikkawa F; Nawa A; Ino K; Shibata K; Kajiyama H; Nomura S
    Nagoya J Med Sci; 2006 Jan; 68(1-2):19-26. PubMed ID: 16579172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer.
    Park JY; Heo EJ; Lee JW; Lee YY; Kim TJ; Kim BG; Bae DS
    J Gynecol Oncol; 2016 Mar; 27(2):e20. PubMed ID: 26768783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The impact of systematic lymphadenectomy for early-stage ovarian carcinomas].
    Miyamoto M; Takano M; Goto T; Shibutani T; Matsuura H; Soyama H; Akimoto T; Asai K; Kawashima A; Watanabe A; Kato M; Yoshikawa T; Sasaki N; Hirata J; Sasa H; Furuya K
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1837-40. PubMed ID: 22083192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.